MEK Inhibitor PD-0325901 in Patients With Neurofibromatosis Type 1 (NF1)-Associated Plexiform Neurofibromas

Conditions:   Plexiform Neurofibroma;   Neurofibromatosis Type 1 (NF1) Intervention:   Drug: PD-0325901 oral capsule Sponsor:   SpringWorks Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials